Status:
UNKNOWN
Artificial Intelligence in Large-scale Breast Cancer Screening
Lead Sponsor:
Karolinska University Hospital
Collaborating Sponsors:
Capio Sankt Görans Hospital
Lunit Inc.
Conditions:
Breast Neoplasm Female
Eligibility:
FEMALE
40-74 years
Phase:
NA
Brief Summary
This is a prospective clinical trial following a paired screen-positive design, with the aims to assess the performance of an artificial intelligence (AI) computer-aided detection (CAD) algorithm as a...
Eligibility Criteria
Inclusion
- Participants in regular population-based breast cancer screening at Capio St Göran Hospital
Exclusion
- Incomplete exam (complete exam: mediolateral oblique and craniocaudal images of Left and Right breast)
- Breast implant
- Complete mastectomy (excluded from screening positive group)
- Participant in surveillance program for prior breast cancer
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
55579 Patients enrolled
Trial Details
Trial ID
NCT04778670
Start Date
April 1 2021
End Date
December 1 2024
Last Update
March 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capio St Göran Hospital
Stockholm, Sweden, 11219